AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,548,708 | +29.3% | 93,975 | -28.2% | 0.80% | +24.8% |
| Q1 2023 | $1,198,183 | +21.0% | 130,806 | -5.4% | 0.64% | +24.0% |
| Q4 2022 | $990,271 | +40.7% | 138,306 | -1.6% | 0.52% | +42.1% |
| Q3 2022 | $704,000 | +106.5% | 140,575 | +0.5% | 0.36% | +105.1% |
| Q2 2022 | $341,000 | -46.6% | 139,875 | +49.8% | 0.18% | -45.0% |
| Q1 2022 | $638,000 | -8.9% | 93,375 | +7.7% | 0.32% | -3.3% |
| Q4 2021 | $700,000 | +1.6% | 86,675 | +23.3% | 0.33% | -7.0% |
| Q3 2021 | $689,000 | +63.3% | 70,275 | +11.9% | 0.36% | +57.7% |
| Q2 2021 | $422,000 | -16.1% | 62,775 | +12.9% | 0.23% | -22.3% |
| Q1 2021 | $503,000 | +87.0% | 55,625 | +4.3% | 0.29% | +62.2% |
| Q3 2020 | $269,000 | -7.9% | 53,325 | +47.3% | 0.18% | -11.3% |
| Q2 2020 | $292,000 | +12.7% | 36,200 | +11.0% | 0.20% | -4.2% |
| Q1 2020 | $259,000 | -5.1% | 32,600 | -9.7% | 0.21% | +27.7% |
| Q4 2019 | $273,000 | +82.0% | 36,100 | 0.0% | 0.17% | +72.9% |
| Q3 2019 | $150,000 | +56.2% | 36,100 | +9.1% | 0.10% | +47.7% |
| Q2 2019 | $96,000 | +92.0% | 33,100 | -4.7% | 0.06% | +85.7% |
| Q1 2019 | $50,000 | -43.2% | 34,750 | +1.5% | 0.04% | -51.4% |
| Q4 2018 | $88,000 | -38.0% | 34,250 | +6.2% | 0.07% | -27.3% |
| Q3 2018 | $142,000 | -1.4% | 32,250 | +37.5% | 0.10% | -5.7% |
| Q2 2018 | $144,000 | +30.9% | 23,450 | +55.8% | 0.10% | +29.6% |
| Q1 2018 | $110,000 | +29.4% | 15,050 | +45.4% | 0.08% | +35.0% |
| Q4 2017 | $85,000 | -26.7% | 10,350 | -6.3% | 0.06% | -29.4% |
| Q3 2017 | $116,000 | -4.9% | 11,050 | 0.0% | 0.08% | +1.2% |
| Q2 2017 | $122,000 | +14.0% | 11,050 | 0.0% | 0.08% | +121.1% |
| Q1 2017 | $107,000 | – | 11,050 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,498,838 | $22,889,355 | 11.72% |
| Knoll Capital Management, LLC | 500,000 | $4,580,000 | 7.06% |
| GENDELL JEFFREY L | 5,301,914 | $48,565,532 | 4.55% |
| COWEN AND COMPANY, LLC | 3,732,778 | $34,192,246 | 4.02% |
| Tri Locum Partners LP | 1,327,097 | $12,156,209 | 3.70% |
| Samsara BioCapital, LLC | 1,409,409 | $12,910,186 | 2.67% |
| Altium Capital Management LP | 500,000 | $4,580,000 | 2.54% |
| Vivo Capital, LLC | 3,761,438 | $34,454,772 | 2.39% |
| RTW INVESTMENTS, LP | 5,741,939 | $52,596,161 | 1.10% |
| Knott David M Jr | 291,113 | $2,667 | 1.05% |